hydroxychloroquine and Cancer of Liver

hydroxychloroquine has been researched along with Cancer of Liver in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Avdic, E; Avery, R; Cameron, AM; Chen, PH; Fine, DM; Garibaldi, B; Garneau, WM; Gurakar, A; Hammami, MB; Jain, T; Kim, AK; Liu, G; Monroy Trujillo, JM; Niranjan-Azadi, A; Petty, B; Shah, P; Strout, S	1
Bartolini, D; Dallaglio, K; Galli, F; Piroddi, M; Torquato, P	1
Liang, M; Liu, X; Luo, B; Ouyang, S; Wang, J; Wu, J; Yao, J; Zhao, Z; Zhou, X	1

Reviews

1 review(s) available for hydroxychloroquine and Cancer of Liver

Article	Year
Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Translational research : the journal of laboratory and clinical medicine, 2018, Volume: 193 Topics: Animals; Autophagy; Carcinoma, Hepatocellular; Chloroquine; Humans; Hydroxychloroquine; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; RNA-Binding Proteins	2018

Other Studies

2 other study(ies) available for hydroxychloroquine and Cancer of Liver

Article	Year
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Hepatocellular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hepatitis C; Humans; Hydroxychloroquine; Inflammation; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Pandemics; Pneumonia, Viral; Renal Dialysis; Reoperation; Transplant Recipients; Treatment Outcome	2020
Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy. Cancer letters, 2018, 05-01, Volume: 421 Topics: Animals; Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydroxychloroquine; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiofrequency Ablation; Xenograft Model Antitumor Assays	2018

Article

Year

Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:8

Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Hepatocellular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hepatitis C; Humans; Hydroxychloroquine; Inflammation; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Pandemics; Pneumonia, Viral; Renal Dialysis; Reoperation; Transplant Recipients; Treatment Outcome

2020

Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy.

Cancer letters, 2018, 05-01, Volume: 421

Topics: Animals; Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydroxychloroquine; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiofrequency Ablation; Xenograft Model Antitumor Assays

2018